Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

BioAtla (BCAB) Long-Term Debt Issuances (2020)

BioAtla (BCAB) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $2.1 million as the latest value for Q4 2020.

  • For Q4 2020, Long-Term Debt Issuances changed N/A year-over-year to $2.1 million; the TTM value through Sep 2021 reached $2.1 million, changed N/A, while the annual FY2025 figure was $7.1 million, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $2.1 million in Q4 2020 for BioAtla, up from -$2.1 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $2.2 million in Q2 2020 and bottomed at -$2.1 million in Q3 2020.